Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.

Takahashi, Mina

Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. [electronic resource] - The Journal of endocrinology Dec 2008 - 445-55 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1479-6805

10.1677/JOE-08-0226 doi


Activins--pharmacology
Blotting, Western
Bone Morphogenetic Protein 2--pharmacology
Bone Morphogenetic Protein 4--pharmacology
Bone Morphogenetic Protein 6--pharmacology
Bone Morphogenetic Protein 7--pharmacology
Bone Morphogenetic Protein Receptors, Type I--genetics
Bone Morphogenetic Protein Receptors, Type II--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Electrophoresis, Polyacrylamide Gel
Enzyme Activation--drug effects
Estradiol--pharmacology
Estrogen Receptor alpha--genetics
Estrogen Receptor beta--genetics
Estrogens--pharmacology
Follistatin--genetics
Humans
Microscopy, Fluorescence
Mitosis--drug effects
Oligonucleotide Array Sequence Analysis
Receptors, Estrogen--genetics
Reverse Transcriptase Polymerase Chain Reaction
Steryl-Sulfatase--genetics
p38 Mitogen-Activated Protein Kinases--metabolism